The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOriole Regulatory News (ORR)

Share Price Information for Oriole (ORR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.295
Bid: 0.29
Ask: 0.30
Change: -0.015 (-4.84%)
Spread: 0.01 (3.448%)
Open: 0.31
High: 0.00
Low: 0.00
Prev. Close: 0.31
ORR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

29 Oct 2021 12:13

RNS Number : 7568Q
Oriole Resources PLC
29 October 2021
 

Oriole Resources PLC 

('Oriole Resources' or 'the Company' or 'the Group')

 

Total Voting Rights

 

In compliance with the FCA's Disclosure Guidance and Transparency Rules (the "Rules"), the Company announces that, as at the date of this announcement, it has 1,994,021,336 ordinary shares of 0.1p each in issue. The Company does not hold any shares in treasury and all of the ordinary shares have equal voting rights.

The figure of 1,994,021,336 ordinary shares represents the total voting rights in the Company and may be used by shareholders as the denominator for the calculations by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Rules.

 

 

 

** ENDS **

 

For further information please visit www.orioleresources.com, @OrioleResources on Twitter, or contact:

 

Oriole Resources PLC

Bob Smeeton / Tim Livesey / Claire Bay

 

Tel: +44 (0)20 7830 9650

Blytheweigh (IR/PR contact)

Tim Blythe / Megan Ray / Rachael Brooks

 

Tel: +44 (0)20 7138 3204

Grant Thornton UK LLP

Samantha Harrison / George Grainger

 

Tel: +44 (0)20 7383 5100

Shard Capital Partners LLP

Damon Heath / Erik Woolgar / Isabella Pierre

 

Tel: +44 (0)20 186 9900

 

Notes to Editors:

 

Oriole Resources PLC is an AIM-listed exploration company, operating West Africa. It is focused on early-stage exploration in Cameroon (Bibemi and Wapouzé projects) and the more advanced Senala gold project in Senegal, where IAMGOLD has the option to spend US$8 million to earn a 70% interest. Year two commitments have been met at all three projects. The Company has several interests and royalties in companies operating throughout Africa and Turkey that could deliver future cash flow, and it continues to assess new opportunities in both regions.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRMLBBTMTBTBTB
Date   Source Headline
1st Feb 202312:36 pmRNSSP Angel Initiation Note
31st Jan 202310:37 amRNSTotal Voting Rights
30th Jan 20233:52 pmRNSSP Angel Analyst Coverage
30th Jan 20237:00 amRNSCameroon Exploration Update
23rd Jan 20237:00 amRNSDeath of Cameroon’s Mining Minister
18th Jan 20232:05 pmRNSSecond Price Monitoring Extn
18th Jan 20232:00 pmRNSPrice Monitoring Extension
5th Jan 20237:00 amRNSInvestor Presentation
4th Jan 20237:00 amRNSUpdate on Salary Sacrifice Scheme
3rd Jan 20237:00 amRNSTotal Voting Rights
21st Dec 20227:00 amRNSUpdate on Senala Gold Project in Senegal
15th Dec 20222:35 pmRNSUpdate on Salary Sacrifice Scheme
15th Dec 20227:00 amRNSChange of Registered Office
13th Dec 202212:42 pmRNSSP Angel Analyst Coverage
12th Dec 20224:40 pmRNSSecond Price Monitoring Extn
12th Dec 20224:35 pmRNSPrice Monitoring Extension
12th Dec 202212:10 pmEQSOriole Resources delivers 'first-ever JORC mineral resource estimate for orogenic gold in Cameroon'
12th Dec 20227:00 amRNSMaiden JORC Resource for Bibemi Gold Project
9th Dec 20227:00 amRNSUpdate on Thani Stratex Resources
30th Nov 20227:00 amRNSTotal Voting Rights
29th Nov 20227:00 amRNSCameroon Exploration Update
14th Nov 20221:00 pmRNSINVESTOR MEETINGS
14th Nov 202210:47 amEQSOriole Resources running a tight ship heading into a new field season
3rd Nov 202210:30 amRNSInvestor Presentation
2nd Nov 20227:00 amRNSUpdate on Salary Sacrifice Scheme
28th Oct 20224:51 pmRNSCORPORATE BROKER
28th Oct 202211:00 amRNS£600k Placing, including Director’s subscriptions
19th Oct 20222:00 pmRNSUpdate on Thani Stratex Resources
10th Oct 202212:26 pmRNSShard Capital Analyst Coverage
10th Oct 20227:00 amRNSBibemi JORC Exploration Target
3rd Oct 20227:00 amRNSBibemi Receives Two-Year Licence Extension
30th Sep 202211:15 amRNSShard Capital Analyst Coverage
29th Sep 20227:00 amRNSSenala Exploration Update
28th Sep 20227:00 amRNSInterim Results
15th Sep 20224:41 pmRNSSecond Price Monitoring Extn
15th Sep 20224:35 pmRNSPrice Monitoring Extension
15th Sep 20222:00 pmRNSPrice Monitoring Extension
15th Sep 20229:58 amRNSShard Capital Analyst Coverage
15th Sep 20227:00 amRNSBibemi Phase 4 Drilling Results
31st Aug 20227:00 amRNSTotal Voting Rights
17th Aug 20227:00 amRNSFurther Gold Targets identified
1st Aug 20227:00 amRNSUpdate on Salary Sacrifice Scheme
29th Jul 20227:00 amRNSTotal Voting Rights
21st Jul 20227:00 amRNSCameroon Exploration Update
8th Jul 20227:00 amRNSUpdate on Salary Sacrifice Scheme
29th Jun 20225:34 pmRNSInvestor Video
29th Jun 20227:15 amRNSSalary Sacrifice Scheme
29th Jun 20227:00 amRNSFinancing and Update on Bibemi Drilling
22nd Jun 20227:00 amRNSUpdated EIA Report Submitted for Muratdere Project
15th Jun 20227:00 amRNSBibemi Exploration Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.